pazopanib and its Impurities
Pazopanib is a drug used in the treatment for advanced/metastatic renal cell carcinoma and advanced soft tissue sarcomas. It is a potent and selective multi-targeted receptor tyrosine kinase inhibitor.Reference standards of Pazopanib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
N2-(2-Chloropyrimidin-4-yl)-N2,N4-bis(2,3-dimethyl-2H-indazol-6-yl)-N4-methylpyrimidine-2,4-diamine
N2-(2-Chloropyrimidin-4-yl)-N2,N4-bis(2,3-dimethyl-2H-indazol-6-yl)-N4-methylpyrimidine-2,4-diamine
Catalogue No.:PA 43 36530
CAS :
1252927-44-8
Molecular Formula : C27H25ClN10
Molecular Weight : 525.01
N,2,3-Trimethyl-N-(2-((4-methyl-3-sulfamoylphenyl)amino)pyrimidin-4-yl)-2H-indazol-6-amine Oxide
N,2,3-Trimethyl-N-(2-((4-methyl-3-sulfamoylphenyl)amino)pyrimidin-4-yl)-2H-indazol-6-amine Oxide
Catalogue No.:PA 43 36670
CAS :
1821666-73-2
Molecular Formula : C21H23N7O3S
Molecular Weight : 453.52
2,3-Dimethyl-6-(methyl(2-((4-methyl-3-sulfamoylphenyl)amino)pyrimidin-4-yl)amino)-2H-indazole 2-oxide
2,3-Dimethyl-6-(methyl(2-((4-methyl-3-sulfamoylphenyl)amino)pyrimidin-4-yl)amino)-2H-indazole 2-oxide
Catalogue No.:PA 43 36680
CAS :
1821666-74-3
Molecular Formula : C21H23N7O3S
Molecular Weight : 453.52
5-((2-((2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-4-yl)amino)-2-methylbenzenesulfonamide
5-((2-((2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-4-yl)amino)-2-methylbenzenesulfonamide
Catalogue No.:PA 43 36690
CAS :
2369664-19-5
Molecular Formula : C21H23N7O2S
Molecular Weight : 437.52
5-((4-((1,2-Dihydroazeto[1,2-b]indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide
5-((4-((1,2-Dihydroazeto[1,2-b]indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide
Catalogue No.:PA 43 0361002
CAS :
1821666-72-1
Molecular Formula : C21H21N7O2S
Molecular Weight : 435.51
5-((4-((2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)(hydroxy)amino)-2-methylbenzenesulfonamide
5-((4-((2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)(hydroxy)amino)-2-methylbenzenesulfonamide
Catalogue No.:PA 43 0361004
CAS :
NA
Molecular Formula : C21H23N7O3S
Molecular Weight : 453.52
5-((4-((2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)(nitroso)amino)-2-methylbenzenesulfonamide
5-((4-((2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)(nitroso)amino)-2-methylbenzenesulfonamide
Catalogue No.:PA 43 0361009
CAS :
NA
Molecular Formula : C21H22N8O3S
Molecular Weight : 466.52
5-((4-((2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-N-((5-((4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylphenyl)sulfonyl)-2-methylbenzenesulfonamide
5-((4-((2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-N-((5-((4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylphenyl)sulfonyl)-2-methylbenzenesulfonamide
Catalogue No.:PA 43 0361013
CAS :
2095544-42-4
Molecular Formula : C42H43N13O4S2
Molecular Weight : 858.01
5-((4-((2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonic Acid
5-((4-((2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonic Acid
Catalogue No.:PA 43 0361016
CAS :
2795176-90-6
Molecular Formula : C21H22N6O3S
Molecular Weight : 438.51
N2,N4-bis(2,3-Dimethyl-2H-indazol-6-yl)-N4-(4-((2,3-dimethyl-2H-indazol-6-yl)amino)pyrimidin-2-yl)pyrimidine-2,4-diamine
N2,N4-bis(2,3-Dimethyl-2H-indazol-6-yl)-N4-(4-((2,3-dimethyl-2H-indazol-6-yl)amino)pyrimidin-2-yl)pyrimidine-2,4-diamine
Catalogue No.:PA 43 0361018
CAS :
1226499-99-5
Molecular Formula : C35H33N13
Molecular Weight : 635.74